Transarterial Radioembolization (TARE) Y-90 is a minimally invasive therapy for liver cancer that uses radioactive Yttrium-90 particles to destroy tumor cells directly from within the blood vessels supplying the cancer. Through this technique, radiation can be delivered more precisely to tumor tissue without causing excessive damage to surrounding healthy liver tissue. Compared to Transarterial Chemoembolization (TACE), TARE Y-90 offers several advantages, including milder side effects, more accurate tumor targeting, and better effectiveness for large or difficult-to-treat tumors.
In Indonesia, TARE Y-90 is available at Mandaya Royal Hospital Puri as one of the advanced services for liver cancer treatment. Supported by modern technology and a team of experienced specialists, this procedure serves as a contemporary treatment option that can help improve outcomes as well as the quality of life of liver cancer patients.
Contents
Understanding the Advantages of TARE Y-90 Compared to TACE in Liver Cancer Treatment
In general, TARE Y-90 is often considered a more advanced and targeted approach, offering better outcomes with lower toxicity for intermediate to advanced-stage liver cancer compared to TACE.
Here are several advantages of TARE Y-90 over TACE in liver cancer treatment:
1. Milder Side Effects (Minimal Post-Embolization Syndrome)
TARE causes significantly fewer post-embolization symptoms (such as pain, fever, and nausea) compared to TACE, regardless of tumor size. TACE is known to have more side effects, which may prolong hospital stays.
2. More Precise Tumor Targeting
TARE Y-90 delivers high-dose beta radiation directly to cancer cells, maximizing tumor destruction while preserving surrounding healthy liver tissue.
3. Longer Time to Progression (TTP)
TARE has been shown to be more effective in delaying disease progression compared to TACE.
4. Effective for Large Tumors and Portal Vein Thrombosis (PVT)
TARE is generally considered superior for patients with large liver tumors (>6 cm) and those with portal vein thrombosis (PVT), a condition that often limits the use of TACE.
5. Better Quality of Life
Due to fewer side effects and better tolerability, patients undergoing TARE often report improved quality of life compared to those receiving TACE.
6. Potential for Downstaging or Bridging to Transplant
TARE is more effective in shrinking tumors (downstaging), allowing patients who were initially ineligible for surgery to become candidates for liver resection or transplantation.
7. Fewer Treatment Cycles Required
One of the key advantages of TARE Y-90 is the reduced number of treatment cycles needed. Typically, TARE Y-90 requires only 1–2 sessions to achieve optimal results, whereas TACE often requires 4–5 repeated cycles. This makes TARE more convenient for patients, reducing hospital visits as well as physical and emotional burden during treatment.
8. Higher Treatment Response and Fewer Side Effects
According to a study published in Frontiers in Oncology (2024), TARE using Yttrium-90 demonstrates a significantly higher treatment response rate compared to TACE. In addition, TARE Y-90 can help prolong survival in patients with hepatocellular carcinoma (HCC). It is also associated with fewer treatment-related side effects, making it a more tolerable and safer option for long-term management.
How Does TARE Y-90 Work to Treat Liver Cancer Without Surgery?
In general, the TARE Y-90 procedure involves the following steps:
- The doctor performs a mapping angiogram to identify blood vessels supplying the liver tumor.
- The mapping results are used to determine the optimal pathway for delivering Y-90 particles.
- Micro-particles containing Yttrium-90 are injected into the blood vessels leading to the tumor.
- These particles travel through the bloodstream until they reach the tumor tissue.
- Once in place, Y-90 emits high-dose radiation to destroy cancer cells.
- The radiation is highly targeted, minimizing damage to surrounding healthy liver tissue.
- With better tumor control, patients may experience longer survival, reduced symptoms, and improved quality of life.
Who Is Eligible for TARE Y-90 Therapy?
TARE Y-90 is generally recommended for patients with the following conditions:
- Patients with primary liver cancer (originating in the liver).
- Patients with cancer that has spread to the liver (metastasis).
- Patients who are not suitable candidates for surgery, for example due to tumor location near major blood vessels.
- Patients who require therapy to slow tumor growth while preserving liver function.
- Patients being prepared for further treatment, such as surgery or liver transplantation, after tumor size has been reduced.
TARE Y-90 Therapy at Mandaya Royal Hospital Puri Performed by dr. Sugi Sp.Rad (K)RI
TARE Y-90 therapy at Mandaya Royal Hospital Puri is performed by dr. Sugianto Santoso, Sp.Rad (K)RI, a radiologist with a subspecialty in interventional radiology and extensive experience in minimally invasive procedures using advanced imaging technology. He completed his medical education at Maranatha Christian University in Bandung and his radiology specialization at the University of Indonesia.
In his clinical practice, dr. Sugianto Santoso manages various medical conditions without the need for open surgery, including liver cancer and other complex diseases. His expertise includes interventional procedures such as Radiofrequency Ablation (RFA) for thyroid nodules, Microwave Ablation (MWA) for tumors and liver cancer, as well as Transarterial Chemoembolization (TACE) as a treatment option for liver cancer.
Supported by advanced medical technology and a minimally invasive approach, dr. Sugi provides safer, more effective, and targeted treatment options for patients. This includes liver cancer management using TARE Y-90 and other interventional procedures available at Mandaya Royal Hospital Puri.
dr. Sugianto Santoso, Sp.Rad (K)RI is available for consultation at Mandaya Royal Hospital Puri on:
- Tuesday: 16:00 – 20:00 WIB
- Thursday: 16:00 – 20:00 WIB.
To make your visit more convenient, you can use the WhatsApp Chat feature, Book Appointment service, or the Care Dokter application available on Google Play and the App Store to schedule visits, check queue numbers, and access more information.
The information provided on this page is intended for educational purposes and general overview only, and does not represent the full scope of medical services offered by each doctor. To receive appropriate treatment based on your condition, it is recommended to consult directly with the relevant doctor.
If you have any questions, suggestions, or need further information, please contact our call center at 0811-1900-2000.
